Evidence map›Paper›PMID 38168828›Full record

ReviewMikrochimica acta2024

Humanized brain organoids-on-chip integrated with sensors for screening neuronal activity and neurotoxicity.

Pelin Saglam-Metiner, Ender Yildirim, Can Dincer, Onur Basak, Ozlem Yesil-Celiktas

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Organoids for disease modeling and treatment: state-of-the-art.Experimental hematology & oncology · 2026
    Review
  4. Review
  5. Biosensor applications in organ-on-a-chip platforms and disease modeling.Frontiers in bioengineering and biotechnology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Pelin Saglam-MetinerDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.
Ender YildirimDepartment of Mechanical Engineering, Middle East Technical University, Ankara, Turkey.
Can DincerDepartment of Microsystems Engineering (IMTEK), University of Freiburg, Freiburg, Germany.
Onur BasakDepartment of Translational Neuroscience, Division of Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Ozlem Yesil-CeliktasDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey. ozlem.yesil.celiktas@ege.edu.tr.ORCID 0000-0003-4509-2212
Utrecht University · NLEge University · TRMiddle East Technical University · TRUniversity of Freiburg · DE

Funding

HORIZON EUROPE Widening Participation and Strengthening the European Research Area 101079473Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 119M578
6 · The paper itself

Abstract

The complex structure and function of the human central nervous system that develops from the neural tube made in vitro modeling quite challenging until the discovery of brain organoids. Human-induced pluripotent stem cells-derived brain organoids offer recapitulation of the features of early human neurodevelopment in vitro, including the generation, proliferation, and differentiation into mature neurons and micro-macroglial cells, as well as the complex interactions among these diverse cell types of the developing brain. Recent advancements in brain organoids, microfluidic systems, real-time sensing technologies, and their cutting-edge integrated use provide excellent models and tools for emulation of fundamental neurodevelopmental processes, the pathology of neurological disorders, personalized transplantation therapy, and high-throughput neurotoxicity testing by bridging the gap between two-dimensional models and the complex three-dimensional environment in vivo. In this review, we summarize how bioengineering approaches are applied to mitigate the limitations of brain organoids for biomedical and clinical research. We further provide an extensive overview and future perspectives of the humanized brain organoids-on-chip platforms with integrated sensors toward brain organoid intelligence and biocomputing studies. Such approaches might pave the way for increasing approvable clinical applications by solving their current limitations.

Indexed as

Induced Pluripotent Stem CellsNervous System DiseasesBrainHumansNeuronsOrganoidsBiocomputingBioengineeringBrain organoidsMicrofluidicsOrganoid-on-a-chipSensors

Identifiers

PMID38168828
OpenAlexW4390546746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.